TikTok Shop Updates U.S. OTC Drug Sales Requirements
TikTok Shop updates its U.S. OTC drug requirements and classifies infant and baby OTC drugs as a high-risk subcategory.
What are the key facts?
- 1TikTok Shop updated its U.S. OTC drug sales requirements on October 1, 2026
- 2Sellers must meet platform eligibility requirements and contact an Account Manager to confirm sales authorization
- 3Infant and baby OTC drugs are classified as a High Risk subcategory
- 4The policy covers pain relievers, cold medicines, allergy medicines, topical medicines, and children’s medicines
- 5Sellers must verify U.S. drug classification, Drug Facts labeling, ingredients, and warnings
What happened?
TikTok Shop updated its U.S. OTC drug sales requirements on October 1, 2026. Before selling these products, sellers must first meet the platform’s category eligibility requirements and contact their Account Manager to determine whether they have sales authorization. All sellers must also comply with federal, state, and local drug regulations, FDA labeling requirements, and applicable DEA rules.
The platform classifies infant and baby OTC drugs as a High Risk subcategory, meaning these products may require additional documents, label review, or stricter product approval. The policy affects cross-border sellers of pain relievers, cold medicines, allergy medicines, topical medicines, children’s medicines, and other OTC drugs. Sellers cannot list products solely because they are legally sold locally or similar products already appear on the platform. They must also verify the U.S. drug classification, Drug Facts label, ingredients, warnings, and applicable age range. Non-compliant products may be delisted and affect account health.
What does this mean for cross-border sellers?
Before selling OTC drugs on the U.S. site, sellers must meet platform eligibility requirements and confirm sales authorization. Infant and baby OTC drugs are also classified as a High Risk subcategory. Platform approval, U.S. drug classification, and Drug Facts labeling must be treated as prerequisites for listing; otherwise, products may be delisted and account health may be affected.
What should sellers do now?
- 1This week, pause new U.S. OTC drug listings, contact the Account Manager for each store to confirm sales authorization, save the responses, and create an authorization ledger by pain relievers, cold medicines, allergy medicines, topical medicines, and other categories; do not publish unconfirmed Listings.Listing character checker
- 2Review the U.S. drug classification, Drug Facts label, ingredients, warnings, and applicable age range for each infant, children’s, and other OTC product. Submit products for review only after completing the documentation, and produce a Listing-by-Listing verification table.Listing Optimizer